Latest 13F institutional holdings

Hilltop Holdings Inc.'s latest 13F filing reveals the firm held $1,583,680,286 in managed assets as of December 31, 2024, across 1,353 holdings.

Enstar Group LTD's latest 13F filing unveils its holdings as of December 31, 2024, showcasing significant investments in various financial sector companies and ETFs.

A comprehensive overview of a fund's holdings has been filed with the SEC, detailing positions in various securities.

Nomura Holdings Inc's latest 13F filing for Q4 2024 discloses holdings valued at over $74 billion across 2,650 positions.

Immersion Corp's latest 13F filing discloses $155.8 million in managed securities as of December 31, 2024, with significant positions in Barnes & Noble Education, Everspin Technologies, Five Point Holdings, MagnaChip Semiconductor, and Universal Electronics.

Toronto Dominion Bank's latest 13F filing reveals a diverse portfolio with substantial holdings in technology, finance, and resource companies as of December 31, 2024.

Alibaba Group Holding Ltd's latest 13F filing reveals its holdings as of December 31, 2024, including significant positions in XPeng Inc, Weibo Corp, and Perfect Corp.

Blackstone Inc.'s latest 13F filing reveals its holdings as of December 31, 2024, showcasing a diverse portfolio with a total value of approximately $21.97 billion.

Berkshire Hathaway's latest 13F filing discloses its equity holdings as of December 31, 2024, revealing significant investments in companies like Apple, Bank of America, and Coca-Cola.

An amended institutional investment manager holdings report has been filed with the SEC, detailing changes in investment portfolios.

TrustCo Bank Corp N Y's latest 13F filing reveals its holdings as of December 31, 2024, showcasing a diverse portfolio of 128 stocks valued at approximately $92.7 million.

Brookfield Corp's latest 13F filing reveals its holdings as of December 31, 2024, showcasing a diverse portfolio with a total value of approximately $16.4 billion.

Financial giant Northern Trust Corp has revealed its investment portfolio, showcasing significant stakes in major companies across various sectors.

Financial Gravity Companies, Inc. reports managing $437.8 million in assets across 1,006 holdings as of December 31, 2024, according to its latest 13F filing.

Jefferies Financial Group Inc. reports $16.7 billion in managed 13F securities as of December 31, 2024, across 1,552 positions.

Regions Financial Corp's latest 13F filing reveals its holdings as of December 31, 2024, with a total portfolio value of approximately $13.6 billion.

Westwood Holdings Group Inc. reports \$12.99 billion in managed 13F securities across 483 holdings as of December 31, 2024.

Royal Bank of Canada files Form 13F-HR, disclosing its holdings as of December 31, 2024.

S&T Bancorp Inc reports no holdings for the quarter ended December 31, 2024, indicating all holdings are reported by other managers.

Bank of America Corp has disclosed its holdings in a comprehensive 13F-HR filing with the SEC, detailing significant investments across a wide range of sectors.

Pfizer Inc's latest 13F filing discloses a diverse investment portfolio with a total value of over $2.5 billion as of December 31, 2024.

Loews Corp's latest 13F filing reveals significant holdings, including a substantial position in CNA Financial Corporation.

CNA Financial Corp's latest 13F filing reveals its equity holdings as of December 31, 2024, totaling over $161 million.

Barclays Bank PLC reports no holdings for the quarter ending December 31, 2024, in its latest 13F filing.

Janus Henderson Group PLC's latest 13F filing discloses its holdings as of December 31, 2024, showcasing a diverse portfolio valued at over $196 billion.

Ameriprise Financial Inc.'s latest 13F filing discloses its holdings as of December 31, 2024, showcasing a diverse investment portfolio.

AlTi Global, Inc. reports its Q4 2024 holdings, revealing significant positions in various equities and ETFs with a total value of approximately $4.14 billion.

Sanofi's latest 13F filing reveals substantial investments in several biotechnology companies, including MeiraGTx Holdings plc and Novavax.

Hancock Whitney Corp's latest 13F filing reveals significant investment positions across diverse sectors as of December 31, 2024, totaling approximately $3.16 billion.

Merck & Co., Inc. reports its holdings for the quarter ended December 31, 2024, revealing significant investments in various biotechnology and pharmaceutical companies.